Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle
—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.
Digital Endpoints and Patient Outcomes in Clinical Trials: Understanding the Differences and Similarities
Delve Health February 28, 2024
In the rapidly evolving landscape of clinical trials, two terms that are gaining significant traction are “digital endpoints” and “patient outcomes.” Both play critical roles
Enhancing Oncology Clinical Trials with Delve Health: A Blend of Innovation and Care
Delve Health February 7, 2024
How Delve Health Supports Gene Therapy Clinical Trials
Delve Health February 7, 2024
The realm of gene therapy presents a new dawn in medical treatment, offering the promise of long-lasting and potentially curative solutions to genetic disorders that
Pat’s Journey to 90% Compliance with Clinical StudyPal
Delve Health February 6, 2024
Let me share with you a story that’s not just about innovation, but about transformation and achievement in the world of clinical trials. This is
The Importance of Patient Engagement in Clinical Trials and Innovative Strategies for Enhancement
Delve Health February 5, 2024
In the realm of healthcare and medical research, the significance of patient engagement in clinical trials cannot be overstated. It is the cornerstone that ensures